MTOR and cancer: The phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway is one of the most frequently deregulated pathways in human cancer and a key regulator of cellular proliferation, growth, and survival.1